Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Http Dx Doi Org 10 1002 Adma 201104290"

22:36 EDT 28th July 2014 | BioPortfolio

Matching Channels

Freiberg Infraction

Freiberg's disease is an osteochondrosis of the metatarsal head, most commonly occurring in young athletes older than 12 years who perform on their toes in either sprinting or jumping activities...

Pediculosis - louse (lice) treatment

   To view our most recent articles on Lice Treatment please go to: http://www.bioportfolio.com/news/article/987636/Pediculosis-Louse-Lice-Treatment.html    

Pediculosis - louse (lice) infestation

   To view our most recent article on Lice Infestation please go to: http://www.bioportfolio.com/news/article/987568/Pediculosis-Louse-Lice-Infestation.html 

Pediculosis - louse (lice) diagnosis

   To view our most recent articals on Lice Diagnosis please view: http://www.bioportfolio.com/news/article/987588/Pediculosis-Louse-Lice-Diagnosis.html

G-protein-coupled receptors (GPCRs)

GPCRs are a large family of cell surface receptors that respond to a variety of external signals. Binding of a signaling molecule to a GPCR results in G protein activation, which in turn triggers th...

Matching News

Esperion begins dosing for ETC-1002 Phase II trial in hypercholesterolemia, hypertension patients

US-based biopharmaceutical firm Esperion Therapeutics has dosed the first patient in its Phase II clinical trial of ETC-1002 to treat patients with hypercholesterolemia and hypertension, ETC-1002-014.

ADMA Biologics reports consolidated net loss of $15.5M in 2013

ADMA Biologics, Inc., a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious...

ADMA completes debt financing

ADMA Biologics to Present at 9th Annual JMP Securities Healthcare Conference on June 24

ADMA Biologics, Inc. (OTCQB: ADMA), a late stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment an...

TIC10 potential cancer drug structure established

10.1002/ange.201402133

Chemists have determined the true structure of promising new drug TIC10

10.1002/ange.201402133

Esperion Therapeutics to Deliver Three Scientific Poster Presentations at the 2014 Annual Scientific Sessions of the National Lipid Association

Esperion Therapeutics, Inc. (Nasdaq: ESPR) today announced the company will deliver three posters featuring ETC-1002 Phase 2 clinical results at the 2014 Annual Scientific Session...

Quark Pharmaceuticals Reports Favorable Results From Phase II Clinical Trial Evaluating Investigational siRNA QPI-1002

Data on siRNA for the Prophylaxis of Delayed Graft Function in Deceased Donor Kidney Transplant Patients Presented at World Transplant Congress Proof of Concept for First-in-Class Systemically D...

Matching PubMed Articles

Rejoinder.

This is the reply to the discussion of the two companion articles on the theory and application of "probability estimation with machine learning methods for dichotomous and multicategory outcome" by K...

ADMA Levels and Arginine/ADMA Ratios Reflect Severity of Disease and Extent of Inflammation After Subarachnoid Hemorrhage.

Subarachnoid hemorrhage (SAH) is characterized by an inflammatory response that might induce endothelial dysfunction. The aim of this study was to evaluate if ADMA and arginine/ADMA ratios after SAH (...

The Endothelial ADMA/NO Pathway in Hypoxia-Related Chronic Respiratory Diseases.

Since its discovery, many adhere to the view that asymmetric dimethylarginine (ADMA), as an inhibitor of the synthesis of nitric oxide (NO), contributes to the pathogenesis of various diseases. Partic...

Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease.

There is growing evidence that increased levels of the endogenous NO synthase inhibitor asymmetric dimethylarginine (ADMA) may contribute to endothelial dysfunction. Studies in animal models as well a...

Dimethylarginines: endogenous inhibitors of nitric oxide synthesis in children with falciparum malaria.

Background. Nitric oxide (NO) bioavailability is impaired in children and adults with severe falciparum malaria (SM). Asymmetric-dimethylarginine (ADMA) limits NO production by inhibiting NO synthas...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement